Updated Coverage – Westwater Resources (WWR)

We have updated coverage of energy materials developer Westwater Resources (WWR) following report of financial resulting in the quarter ending March 2018, and other developments in the Company’s asset portfolio. In April 2018, Westwater completed the previously announced acquisition of Alabama Graphite.  Management confirmed plans to develop what could be the first domestic source of […]

Read More

Updated Coverage – PreveCeutical Medical (PRVCF)

Our coverage of PreveCeutical Medical (PRVCF) is updated with comments on recent progress with the Company’s portfolio of research and development projects focused on preventative therapeutics.   The Company has several major achievements in recent months, moving the R&D pipeline closer to goals. In March 2018, the Company’s research and development partner UniQuest Pty. Ltd. began […]

Read More

New Coverage – PreveCeutical Medical (PRVCF)

PreveCeutical Medical is biomedical company focused on preventative health sciences using organic and nature-identical compounds.  The Company was recently organized to pursue market opportunities for a novel therapy based on blue scorpion venom.  PreveCeutical markets an  CELLB9, an oral solution of blue scorpion venom for use without prescription.  The solution has been found instrumental in […]

Read More